GMO (Jeremy Grantham) — GSK Trade History
Quarter-by-quarter changes in the GSK PLC position · CUSIP 37733W204
Currently held · 4 YearsFirst seen: 2022 Q3split-adjusted
| Quarter | Filed | Activity | Shares | Δ Shares | Δ % | Value | % Port. |
|---|---|---|---|---|---|---|---|
| 2026 Q2 | 2026-08-13 | Add | 3,599,521 | 76,955 | +2.2% | $188.7M | 0.42% |
| 2026 Q1 | 2026-05-14 | Add | 3,522,566 | 33,192 | +1.0% | $194.4M | 0.50% |
| 2025 Q4 | 2026-02-17 | Add | 3,489,374 | 917,248 | +35.7% | $171.1M | 0.44% |
| 2025 Q3 | 2025-11-13 | Reduce | 2,572,126 | -29,449 | -1.1% | $111.0M | 0.31% |
| 2025 Q2 | 2025-08-13 | Add | 2,601,575 | 460,904 | +21.5% | $99.9M | 0.30% |
| 2025 Q1 | 2025-05-14 | Reduce | 2,140,671 | -2,012,945 | -48.5% | $82.9M | 0.26% |
| 2024 Q4 | 2025-02-13 | Add | 4,153,616 | 446,568 | +12.0% | $140.5M | 0.46% |
| 2024 Q3 | 2024-11-13 | Add | 3,707,048 | 561,718 | +17.9% | $151.5M | 0.47% |
| 2024 Q2 | 2024-08-13 | Add | 3,145,330 | 1,636,365 | +108.4% | $121.1M | 0.41% |
| 2024 Q1 | 2024-05-14 | Reduce | 1,508,965 | -169,984 | -10.1% | $64.7M | 0.23% |
| 2023 Q4 | 2024-02-13 | Add | 1,678,949 | 412,505 | +32.6% | $62.2M | 0.28% |
| 2023 Q3 | 2023-11-13 | Add | 1,266,444 | 634,070 | +100.3% | $45.9M | 0.22% |
| 2023 Q2 | 2023-08-14 | Add | 632,374 | 473,664 | +298.4% | $22.5M | 0.10% |
| 2023 Q1 | 2023-05-12 | Reduce | 158,710 | -144,700 | -47.7% | $5.6M | 0.03% |
| 2022 Q4 | 2023-02-13 | Reduce | 303,410 | -1,837,510 | -85.8% | $10.7M | 0.06% |
| 2022 Q3 | 2022-11-10 | New | 2,140,920 | 2,140,920 | — | $63.0M | 0.36% |
| 2022 Q2 | 2022-08-12 | — | — | — | — | — | — |
| 2022 Q1 | 2022-05-13 | — | — | — | — | — | — |
| 2021 Q4 | 2022-02-11 | — | — | — | — | — | — |
| 2021 Q3 | 2021-11-12 | — | — | — | — | — | — |
| 2021 Q2 | 2021-08-12 | — | — | — | — | — | — |
| 2021 Q1 | 2021-05-13 | — | — | — | — | — | — |
| 2020 Q4 | 2021-02-12 | — | — | — | — | — | — |
| 2020 Q3 | 2020-11-13 | — | — | — | — | — | — |
| 2020 Q2 | 2020-08-13 | — | — | — | — | — | — |
| 2020 Q1 | 2020-05-14 | — | — | — | — | — | — |
| 2019 Q4 | 2020-02-13 | — | — | — | — | — | — |
| 2019 Q3 | 2019-11-13 | — | — | — | — | — | — |
| 2019 Q2 | 2019-08-13 | — | — | — | — | — | — |
| 2019 Q1 | 2019-05-14 | — | — | — | — | — | — |
| 2018 Q4 | 2019-02-13 | — | — | — | — | — | — |
| 2018 Q3 | 2018-11-14 | — | — | — | — | — | — |
| 2018 Q2 | 2018-08-14 | — | — | — | — | — | — |
| 2018 Q1 | 2018-05-15 | — | — | — | — | — | — |
| 2017 Q4 | 2018-02-14 | — | — | — | — | — | — |
| 2017 Q3 | 2017-11-14 | — | — | — | — | — | — |
| 2017 Q2 | 2017-08-14 | — | — | — | — | — | — |
| 2017 Q1 | 2017-05-15 | — | — | — | — | — | — |
| 2016 Q4 | 2017-02-13 | — | — | — | — | — | — |
| 2016 Q3 | 2016-11-10 | — | — | — | — | — | — |
Share counts are split-adjusted. Time held counts consecutive quarters ending with the latest filing; more than ten years shows as ">10 Years".
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.